FDA-Approved Nasal Spray For Depression Is 1st Of Its Kind
The FDA just approved this ketamine-derived nasal spray for depression treatment
The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone treatment for adults with major depressive disorder who have not responded to at least two other antidepressants.
They can help you find out if a nasal spray may be beneficial for your acute migraine symptoms. They can also inform you of any side effects or interactions to watch out for. Healthline has strict ...
PH284 increased feelings of hunger and was safe in patients with cancer cachexia, which results in significant weight loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback